2 Results for "

ATG13 phosphorylation

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "ATG13 phosphorylation" in MCE Product Catalog:

Cat. No.: HY-181699
Target:  

ULK

Research Areas:  

Cancer

ULK1-IN-5 (Compound D1) is a selective ULK1 inhibitor with an IC50 of 14.91 nM. ULK1-IN-5 functionally inhibits the kinase activity of ULK1. ULK1-IN-5 reduces the phosphorylation level of ATG13. ULK1-IN-5 exerts antiproliferative effects on cervical cancer cells. ULK1-IN-5 is applicable to relevant research on cervical cancer .
loading...
    loading...
Cat. No.: HY-181815
CAS No.: 1884222-37-0
Research Areas:  

Cancer

SBP-5147 is an orally active ULK1/ULK2 inhibitor, with an IC50 of 2 nM against ULK1 and an IC50 of 53 nM against ULK2. SBP-5147 inhibits the phosphorylation of Beclin-1 and Vps34, reduces autophagy flux, downregulates the expression of ATG13 and ATG101, upregulates the expression of MHC-I, induces caspase-dependent apoptosis, and decreases the viability of non-small cell lung cancer cells. SBP-5147 is applicable to research related to non-small cell lung cancer [1] .
loading...
    loading...